Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
2(25%)
Results Posted
100%(4 trials)
Terminated
2(25%)

Phase Distribution

Ph phase_1
3
38%
Ph phase_3
2
25%
Ph phase_2
1
13%
Ph phase_4
2
25%

Phase Distribution

3

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
3(37.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Terminated(2)

Detailed Status

Completed4
Recruiting2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (37.5%)
Phase 21 (12.5%)
Phase 32 (25.0%)
Phase 42 (25.0%)

Trials by Status

recruiting225%
terminated225%
completed450%

Recent Activity

2 active trials
Showing 5 of 8
terminatedphase_4

Acute Migraine Treatment in the ED With Gepants

NCT06985342
recruitingphase_1

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

NCT06995729
recruitingphase_4

Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications

NCT06401642
completedphase_3

A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults

NCT05989048
completedphase_1

A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult Participants

NCT05960032
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06985342Phase 4

Acute Migraine Treatment in the ED With Gepants

Terminated
NCT06995729Phase 1

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

Recruiting
NCT06401642Phase 4

Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications

Recruiting
NCT05989048Phase 3

A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults

Completed
NCT05960032Phase 1

A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult Participants

Completed
NCT04987944Phase 1

Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma

Terminated
NCT03872453Phase 2

Acute Treatment Trial in Adult Subjects With Migraines

Completed
NCT04571060Phase 3

Randomized Trial in Adult Participants With Acute Migraines

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8